Mukesh Verma, Ph.D.
Branch Chief, Methods and Technologies Branch
National Institutes of Health
National Cancer Institute
Epidemiology and Genomics Research Program
Division of Cancer Control and Population Sciences
9609 Medical Center Drive, Rm. 4E102, MSC 9763
Bethesda, MD 20892
(For express delivery, use Rockville, MD 20850)
telephone: (240) 276-6889
Ph.D. - Host-virus Interaction
Banaras Hindu University
M.Sc. - Biochemistry (Major) and Microbiology (Minor)
B.Sc. - Biological Sciences
Biomarkers, epigenetics, epidemiology technologies, proteomics, microRNA, methylation, mitochondria, nanotechnology, risk assessment, susceptibility factors, and systems genetics.
Dr. Verma is Chief of the Epidemiology and Genomics Research Program's (EGRP) Methods and Technologies Branch (MTB), and oversees its research portfolio and initiatives that focus on methods to address epidemiologic data collection, study design and analysis, and to modify technological approaches developed in the context of other research endeavors for use as biomarkers and methods to understand cancer susceptibility.
He is responsible for stimulating EGRP-funded research on epigenetic approaches in cancer epidemiology and has been instrumental in developing epigenetics research for NIH as a whole. Dr. Verma helped to develop a Request for Applications (RFA) on Environmental Influences on Epigenetics with the National Institute of Environmental Health Sciences (NIEHS) and represents the Division of Cancer Control and Population Sciences (DCCPS), in NIH's Roadmap Initiative on Epigenetics. He helped develop an RFA on Comparative Systems Genetics of Cancer with NCI's Division of Cancer Biology (DCB), and is known within the extramural research community as an EGRP Program Director for Program Announcements (PAs) on Small Grants for Cancer Epidemiology and Pilot Studies in Pancreatic Cancer. He also organized a workshop to explore developing a concept for a research initiative on mitochondrial DNA and cancer epidemiology.
Dr. Verma was, and continues to be, a co-Program Director for initiatives in gene-environment interactions in cancer etiology, including the Breast and Prostate Cancer and Hormone-Related Variants Cohort Consortium (BPC3), which is a collaborative project to pool data and biospecimens from a group of large prospective cancer epidemiology cohorts.
Dr. Verma joined EGRP as a Program Director in 2004. In 2005, he was appointed Acting Chief of EGRP's former Analytic Epidemiology Research Branch (AERB). When EGRP reorganized in 2007, he was appointed Acting Chief of MTB and of the Host Susceptibility Factors Branch (HSFB), for which he served as Acting Chief through 2008. Before joining EGRP, he was a Program Director in NCI's Division of Cancer Prevention (DCP), where he worked in the areas of biomarkers, early detection, risk assessment, and prevention. He also was Coordinator of DCP's Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs. He was on the faculty in the Biochemistry Department of Georgetown University before joining NIH.
Verma, M. (2009). Human epigenome and cancer. In: Human Genome Epidemiology, 2nd Edn. (Muin Khoury, Sara Bedrosian, Marta Gwinn, Julian Higgins, John Ioannidis and Julian Little Khoury, M. eds.), Oxford University Press. Pp 551-578.
Verma, M. (2010). Nutritional epigenetics and disease prevention: are we there yet? In: Nutrition, Epigenetic Mechanisms and Human Disease (Maulik N. and Maulik, M., edt.). CRC Press. New York. Pp 1-11.
Verma, M. (2010). Pancreatic cancer biomarkers and their application in cancer diagnosis and epidemiology. Cancers, 2: 1830-1837.
Mishra, A. and Verma, M. (2010). Cancer biomarkers: are we ready for the prime time? Cancers, 2: 190-208.
Banerjee, H. N. and Verma, M. (2011) Quantum dots and their application in cancer detection and therapy. International Journal of Biomedical Science and Nanotechnologies (IJBNN). 2: 33-43.